Xiaflex collagenase clostridium histolyticum regulatory update

The European Commission approved Xiapex collagenase clostridium histolyticum from Swedish Orphan to treat Peyronie’s disease with a palpable plaque and curvature deformity of 30 degrees. The injectable form of collagenase is also approved in the EU to treat Dupuytren’s contracture in adult patients with a palpable cord, which affects joints in the hand. ...